AURO LABORATORIES
Back to Balance Sheet
|
AURO LABORATORIES Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹2.86 Cr | ₹3.11 Cr | ₹3.69 Cr | ₹4.45 Cr | ₹3.16 Cr |
What is the latest Contingent Liabilities ratio of AURO LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹2.86 Cr |
| Mar2025 | ₹3.11 Cr |
| Mar2024 | ₹3.69 Cr |
| Mar2023 | ₹4.45 Cr |
| Mar2022 | ₹3.16 Cr |
How is Contingent Liabilities of AURO LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.86 Cr | -7.94 | |
| Mar2025 | ₹3.11 Cr | -15.62 | |
| Mar2024 | ₹3.69 Cr | -17.18 | |
| Mar2023 | ₹4.45 Cr | 41.11 | |
| Mar2022 | ₹3.16 Cr | - | |
Compare Contingent Liabilities of peers of AURO LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AURO LABORATORIES | ₹159.3 Cr | 9.1% | 10.7% | 17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
AURO LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | 9.1% |
10.7% |
17.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses